Eyewear that applies voltage to a liquid lens and refocuses automatically for myopia, hyperopia, and presbyopia. A look at where autofocus vision correction stands, centered on HOYA spinoff ViXion's 01S and the ViXion2 released in 2026.
Elevidys, priced at 304.97 million yen, became Japan's most expensive insured drug in February 2026. Coverage is limited to ambulatory patients aged three to seven. The US safety findings behind that limit, and what ultra-expensive drugs mean for universal coverage.
What if your pajamas could heal you while you sleep? In Japan, "recovery wear" (clothing infused with ceramic minerals that emit far-infrared rays to boost blood circulation) has become a national craze, even earning a Word of the Year nomination. Budget chains Workman, Nitori and Aeon have pushed entry prices down to single digits in dollars. Here's what recovery wear is, why millions of Japanese are buying it, and how the sales numbers look through mid-2026.
No batteries. Just 280 grams of rubber. A Japanese bone-setter turned entrepreneur created "futto," a walking support device using rubber tubes as artificial muscles. Built with hardware store materials by a three-person family company, it now has peer-reviewed backing, a distribution deal with France Bed, and sales abroad. Here's how this $220 device answers a problem every aging society shares.
Japan-born IoT wearable "DFree" uses ultrasound to predict urination timing and has won the Grand Prize for Developmental Support Tools at BabyTech Awards 2025-26. How the 20-gram device works, why the judges picked it, how it came to be covered by Japan's long-term care insurance, and what it means for elderly care and children with disabilities.
Beef tendon, a common Japanese hot pot ingredient, is being transformed into knee ligament implant material. A Waseda University startup has developed decellularization technology that could eliminate the need to harvest patients' own tissue for ACL reconstruction. Clinical trials are underway with commercialization targeted for 2028.
Osaka-based Satosen's liquid metal stretchable circuit board has been officially adopted by ATR-Promotions for biosignal measurement electrodes. With self-healing wiring that withstands over 250,000 stretch cycles, this technology opens doors for wearable devices, flexible displays, and soft robotics.
The world's first wired earphones using "cartilage conduction," a third hearing pathway discovered in Japan, are now on sale. How Sound Ball differs from bone conduction, its adoption by five Osaka Expo pavilions, and what it means for the future of audio.
Researchers at the University of Tokyo and the Tokyo Metropolitan Institute of Medical Science have developed a microneedle patch that delivers a COVID-19 vaccine simply by sticking it on the skin. A 3D-printed pillar-guided design lifts tip-loading efficiency to 16.5%, about 8.3 times conventional molding, and mice given the patch showed a 1.2-fold higher antibody response than conventional intradermal injection. How this mouse-stage technology aims at painless, room-temperature, self-applied vaccination.
A Japanese-developed measles-vector vaccine against Nipah virus, a disease with up to 75% fatality, began Phase I clinical trials in Belgium in June 2026. Learn about the approach and Japan's role in global pandemic preparedness.
Instead of pills, prescribe connection — Japan is pioneering the use of metaverse technology as a form of "social prescribing" in healthcare. A team of 35 medical professionals and creators launched "Virtual Brave Beat" on the cluster platform, turning participants into heroes of their own story to combat isolation. We explore how the world's most aged society is leveraging virtual spaces for wellbeing.
Japanese startup Milk. is developing technology that combines satellite-derived "hyperspectral cameras" with color AI to detect cancer—including which organ is affected—from a simple urine test. With 98% accuracy even for pancreatic cancer, this innovation could revolutionize how we screen for humanity's deadliest enemy.
A research team at Kanazawa University has developed a next-generation X-ray CT scanner with 5x the resolution of conventional devices (0.08–0.1mm). Capturing images in just 6.5 seconds, this compact device can visualize trabecular bone structure, opening doors for early detection of trigger finger and osteoarthritis. We look at how 20 years of clinical experience led to it.
Kyushu University and Japan Medical Company are developing the "Hakata Model," a next-generation 3D surgical training platform that reproduces individual patient tumors with high precision, transforming one-time surgical experiences into repeatable hands-on training for neurosurgeons.
Analysis of Japan's latest cancer 5-year survival rate data from the National Cancer Center. While prostate (94%) and thyroid (92%) show high survival rates, pancreatic cancer remains at only 10%. Examining the importance of early detection and 30-year survival trends.
World-first scientific proof that resistance training rejuvenates skin, revealed by Ritsumeikan University and POLA research. Discover how 16 weeks of strength training increases dermal thickness, improves skin elasticity, and reduces wrinkles through myokine secretion and inflammatory factor reduction.
Japanese researchers from RIKEN, Nippon Medical School, and Tohoku University developed a breakthrough AI method for cancer prognosis prediction. By incorporating medical knowledge through "intermediate reasoning scores," the system overcomes the dual challenges of institutional and specimen variations, achieving consistent predictions across different hospitals.
Japan is at the front of smart contact lens development: holographic display technology from Tokyo University of Agriculture and Technology, SEED's open-source platform, and Waseda's electromagnetic shielding. One industry forecast puts the global market at about $13.4 billion by 2030. Discover how Japanese universities and companies are shaping the future of wearable tech.
US healthcare company KindlyMD merged with Nakamoto Holdings, raising $710 million to become a Bitcoin treasury company. Led by David Bailey, the company invested $30 million in Japan's Metaplanet. Explore the potential and risks of corporate Bitcoin strategies.
SFTS is a tick-borne disease with a 10-30% fatality rate. A treatment was approved in 2024, which made early diagnosis the bottleneck. Japanese institutions including Osaka University are developing a 15-minute test on the model of flu antigen kits. 2025 brought a record 183 cases and Hokkaido's first infection.